Tag: precision medicine

June 28, 2018

5 Top NASDAQ Genetic Stocks of Q2 2018

In the final days of Q2 2018, we've profiled the five top NASDAQ genetic stocks year-to-date. Here's a look at...
May 9, 2018

ARCA Biopharma announces first quarter 2018 financial results AND Provides Corporate Update

ARCA biopharma (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today reported...
April 19, 2018

OpGen Completes Rapid Testing Clinical Trial in Colombia and Expands International Operations

OpGen (NASDAQ:OPGN) OpGen announced today that it successfully completed a prospective clinical trial evaluating the impact of using rapid diagnostic...
April 16, 2018

Cancer Genetics’ Unique Tissue of Origin Test Receives Special FDA 510(k) Clearance

Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced that it...
April 12, 2018

Illumina and Loxo Oncology Form Collaboration, Share Prices Increase

Illumina and Loxo have teamed up to develop and commercialize a multi-gene panel for broad tumor profiling for cancer indications.
April 10, 2018

Loxo Oncology and Illumina to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics

Loxo Oncology (Nasdaq:LOXO) and Illumina (Nasdaq:ILMN) announced a global strategic partnership to develop and commercialize a multi-gene panel for broad...
April 3, 2018

Precision Therapeutics Reports Fiscal Year 2017 Financial Results

Precision Therapeutics (NASDAQ:AIPT) formerly Skyline Medical, a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today...